Autoimmune Disease Diagnostic Breakthrough
IQuity’s research reveals that autoimmune patients exhibit distinct RNA expression patterns in their blood. This is a critical breakthrough in the ability to detect autoimmune disease and related conditions as they present. Using the IQIsolate process, our tests can distinguish between difficult to diagnose diseases. For example, the Isolate tests can distinquish multiple sclerosis from other neurological diseases; IBS from Crohn’s and ulcerative colitis; and fibromyalgia from rheumatoid arthritis or lupus.
IQuity’s analytic process, IQIsolate™, uses machine learning to develop algorithms that analyze RNA gene expression in whole blood. IQIsolate™ measures the expression of RNA markers that are extracted from a patient’s blood sample. This RNA analysis distinguishes between healthy and diseased patients identified through our extensive research. IQIsolate™ accurately determines if the patient’s RNA expression pattern is consistent with a specific disease. IQuity’s ability to identify these patterns gives providers information to confirm a suspected diagnosis with analytical accuracy greater than 90%.
Answers. Not Clues.

For nearly 20 years, DNA has been used to craft associations for disease, but it cannot always identify the presence or absence of disease. For many autoimmune diseases, the presence of genetic risk factors does not guarantee that the patient will develop these conditions. IQuity has found that RNA gene expression patterns provide accurate information about real-time activity in immune cells within the blood.